FibroGen limits rare-disease drug’s access after clinical trial failure. Some parents say it was saving their kids’ lives

‘How long before my heart fails?’ Tanner Edwards asked his mom after losing access to a FibroGen drug he’s taken for six years for Duchenne muscular dystrophy.
Click here to view original post

Advertisement — Advertise with Biotech Networks